Research ArticleHuman Studies
Phase I Trial of Iodine-131-Chimeric B72.3 (Human IgG4) in Metastatic Colorectal Cancer
Ruby F. Meredith, M. B. Khazaeli, Walter E. Plott, Mansoor N. Saleh, Tiepu Liu, Laquetta F. Allen, Charles D. Russell, Roger A. Orr, David Colcher, Jeffrey Schlom, Dan Shochat, Richard H. Wheeler and Albert F. LoBuglio
Journal of Nuclear Medicine January 1992, 33 (1) 23-29;
Ruby F. Meredith
M. B. Khazaeli
Walter E. Plott
Mansoor N. Saleh
Tiepu Liu
Laquetta F. Allen
Charles D. Russell
Roger A. Orr
David Colcher
Jeffrey Schlom
Dan Shochat
Richard H. Wheeler
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Phase I Trial of Iodine-131-Chimeric B72.3 (Human IgG4) in Metastatic Colorectal Cancer
Ruby F. Meredith, M. B. Khazaeli, Walter E. Plott, Mansoor N. Saleh, Tiepu Liu, Laquetta F. Allen, Charles D. Russell, Roger A. Orr, David Colcher, Jeffrey Schlom, Dan Shochat, Richard H. Wheeler, Albert F. LoBuglio
Journal of Nuclear Medicine Jan 1992, 33 (1) 23-29;
Phase I Trial of Iodine-131-Chimeric B72.3 (Human IgG4) in Metastatic Colorectal Cancer
Ruby F. Meredith, M. B. Khazaeli, Walter E. Plott, Mansoor N. Saleh, Tiepu Liu, Laquetta F. Allen, Charles D. Russell, Roger A. Orr, David Colcher, Jeffrey Schlom, Dan Shochat, Richard H. Wheeler, Albert F. LoBuglio
Journal of Nuclear Medicine Jan 1992, 33 (1) 23-29;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Molecular Characterization of the Anti-Idiotypic Immune Response of a Relapse-Free Neuroblastoma Patient following Antibody Therapy: A Possible Vaccine against Tumors of Neuroectodermal Origin?
- High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody
- Colorectal Cancer as a Model for Immunotherapy